Enfusion Results Presentation Deck

Dear Shareholders, Since Enfusion's founding, navigating challenging environments has been a part of our journey. From the Global Financial Crisis to the COVID pandemic, following each instance of macroeconomic uncertainty, we have emerged a stronger company. I expect the impact of this current environment to be no different. As it always has, Enfusion creates compelling and unique value for our clients and, in doing so, allows us to maintain our leading position in cloud-native, end-to-end investment management software. 1Q23 Highlights: During the first quarter, Enfusion continued to grow revenue at double-digit rates and further established itself as the partner of choice for investment managers. Two key areas that I am particularly proud of are: ● Our first quarter client wins demonstrate our ongoing strength in conversions and further our global expansion. We signed a multi-billion-dollar venture capital fund that was looking to replace its outdated technology with a cloud-native, end-to-end platform. I am also particularly proud that we signed a credit hedge fund through our relationship with a dedicated managed-account platform, Innocap Global Investment Management. Further, we signed a multi-billion dollar Chinese hedge fund based in Singapore that chose Enfusion to consolidate its incumbent providers onto one platform. We delivered healthy growth and profitability in the face of macro challenges. For the first quarter, we delivered double-digit revenue growth, which was driven by new sales across our products and services. Our focused expense discipline allowed us to maintain a solid margin profile. Further, our strong cash conversion translated to another quarter of positive adjusted free cash flow. Enfusion continues to disrupt the investment management solutions space by creating unparalleled value for all of its clients, which include new hedge fund launches, large complex multi-manager platforms, institutional investment managers, wealth managers, and family offices. Our compelling value proposition centers around our cloud-native, multi-tenant Saas model, which allows us to grow and scale with our clients, drive efficiencies, lower the total cost of ownership, and empower investment managers and asset owners to make better decisions. As one of the few SaaS-based companies with the unique combination of high growth and proven profitability, I am confident that Enfusion remains well-positioned to create long-term shareholder value. Sincerely, a. Morch Oleg Movchan Chief Executive Officer *:enfusion Ⓒ2023 ENFUSION. ALL RIGHTS RESERVED. 3

View entire presentation